3/13/2025

Janusmed kön och genus

Janusmed kön och genus – JYNNEOS

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
B B
B B

Vaccin mot smittkoppor/mpox

Vaccin mot smittkoppor/mpox

Klass : B

Visa all info

Skriv ut

Kontakta oss

  1. Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24.

  2. Mpox outbreak: global trends. World Health Organization (WHO) [www]. [updated 2024-09-10, cited 2024-09-11].

  3. Satapathy P, Shamim MA, Padhi BK, et al. Mpox virus infection in women and outbreak sex disparities: A Systematic Review and Meta-analysis. Commun Med (Lond). 2024;4(1):188.

  4. European Medicines Agency (EMA). Note for guidance on preclinical pharmacological and toxicological testing of vaccines (CPMP/SWP/465/95) [updated 1997-12-17, cited 2021-04-08].

  5. Flanagan KL, Klein SL, Skakkebaek NE, Marriott I, Marchant A, Selin L et al. Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine. 2011;29(13):2349-54.

  6. St Clair LA, Chaulagain S, Klein SL, et al. Sex-Differential and Non-specific Effects of Vaccines Over the Life Course. Curr Top Microbiol Immunol. 2023;441:225-251.

  7. Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA et al. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 2009;27(25):3319-23.

  8. Troy JD, Hill HR, Ewell MG, Frey SE. Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine. Vaccine. 2015;33(41):5425-5431.

  9. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA. Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals. Hum Immunol. 2013;74(10):1263-6.

  10. Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E et al. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States. N Engl J Med. 2023;388(26):2434-2443.

  11. Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.

  12. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med. 1998;60(2):150-5.

  13. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266-75.

  14. Holm L, Ekman E, Jorsäter Blomgren K. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2017;26(3):335-343.

  15. Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ et al. Myopericarditis following smallpox vaccination. Am J Epidemiol. 2004;160(7):642-51.

  16. Statistikdatabas för diagnoser . Stockholm: Socialstyrelsen. 2021 [cited 2022-06-20.]

  17. Cooper LT, Keren A, Sliwa K, Matsumori A, Mensah GA. The global burden of myocarditis: part 1: a systematic literature review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart. 2014;9(1):121-9.

  18. Mattsson G, Levin C, Magnusson P. ABC om - perikardit och myokardit. Lakartidningen. 2018;115.

  19. Chastain DB, Krsak M, Henao-Martínez AF. Sex-based differences in treatment approaches and outcomes among patients with mpox: Limitations of real-world data. Int J STD AIDS. 2024;35(10):808-813.

  1. Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24.
  2. Mpox outbreak: global trends. World Health Organization (WHO) [www]. [updated 2024-09-10, cited 2024-09-11].
  3. Satapathy P, Shamim MA, Padhi BK, et al. Mpox virus infection in women and outbreak sex disparities: A Systematic Review and Meta-analysis. Commun Med (Lond). 2024;4(1):188.
  4. European Medicines Agency (EMA). Note for guidance on preclinical pharmacological and toxicological testing of vaccines (CPMP/SWP/465/95) [updated 1997-12-17, cited 2021-04-08].
  5. Flanagan KL, Klein SL, Skakkebaek NE, Marriott I, Marchant A, Selin L et al. Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine. 2011;29(13):2349-54.
  6. St Clair LA, Chaulagain S, Klein SL, et al. Sex-Differential and Non-specific Effects of Vaccines Over the Life Course. Curr Top Microbiol Immunol. 2023;441:225-251.
  7. Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA et al. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 2009;27(25):3319-23.
  8. Troy JD, Hill HR, Ewell MG, Frey SE. Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine. Vaccine. 2015;33(41):5425-5431.
  9. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA. Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals. Hum Immunol. 2013;74(10):1263-6.
  10. Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E et al. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States. N Engl J Med. 2023;388(26):2434-2443.
  11. Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.
  12. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med. 1998;60(2):150-5.
  13. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266-75.
  14. Holm L, Ekman E, Jorsäter Blomgren K. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2017;26(3):335-343.
  15. Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ et al. Myopericarditis following smallpox vaccination. Am J Epidemiol. 2004;160(7):642-51.
  16. Statistikdatabas för diagnoser . Stockholm: Socialstyrelsen. 2021 [cited 2022-06-20.]
  17. Cooper LT, Keren A, Sliwa K, Matsumori A, Mensah GA. The global burden of myocarditis: part 1: a systematic literature review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart. 2014;9(1):121-9.
  18. Mattsson G, Levin C, Magnusson P. ABC om - perikardit och myokardit. Lakartidningen. 2018;115.
  19. Chastain DB, Krsak M, Henao-Martínez AF. Sex-based differences in treatment approaches and outcomes among patients with mpox: Limitations of real-world data. Int J STD AIDS. 2024;35(10):808-813.